Quantitative PCR analysis reveals a high incidence of large intragenic deletions in the FANCA gene in Spanish Fanconi anemia patients

被引:15
作者
Callén, E
Tischkowitz, MD
Creus, A
Marcos, R
Bueren, JA
Casado, JA
Mathew, CG
Surrallés, J [1 ]
机构
[1] Univ Autonoma Barcelona, Dept Genet & Microbiol, Grp Mutagenesis, E-08193 Barcelona, Spain
[2] Kings Coll London, Guys Kings & St Thomas Sch Med, Div Genet & Dev, London WC2R 2LS, England
[3] CIEMAT, Fdn Marcelino Botin, E-28040 Madrid, Spain
关键词
D O I
10.1159/000077513
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Fanconi anaemia is an autosomal recessive disease characterized by chromosome fragility, multiple congenital abnormalities, progressive bone marrow failure and a high predisposition to develop malignancies. Most of the Fanconi anaemia patients belong to complementation group FA-A due to mutations in the FANCA gene. This gene contains 43 exons along a 4.3-kb coding sequence with a very heterogeneous mutational spectrum that makes the mutation screening of FANCA a difficult task. In addition, as the FANCA gene is rich in Alu sequences, it was reported that Alu-mediated recombination led to large intragenic deletions that cannot be detected in heterozygous state by conventional PCR, SSCP analysis, or DNA sequencing. To overcome this problem, a method based on quantitative fluorescent multiplex PCR was proposed to detect intragenic deletions in FANCA involving the most frequently deleted exons (exons 5, 11, 17, 21 and 31). Here we apply the proposed method to detect intragenic deletions in 25 Spanish FA-A patients previously assigned to complementation group FA-A by FANCA cDNA retroviral transduction. A total of eight heterozygous deletions involving from one to more than 26 exons were detected. Thus, one third of the patients carried a large intragenic deletion that would have not been detected by conventional methods. These results are in agreement with previously published data and indicate that large intragenic deletions are one of the most frequent mutations leading to Fanconi anaemia. Consequently, this technology should be applied in future studies on FANCA to improve the mutation detection rate. Copyright (C) 2003 S. Karger AG, Basel.
引用
收藏
页码:341 / 345
页数:5
相关论文
共 33 条
  • [11] The Fanconi anaemia group G gene FANCG is identical with XRCC9
    de Winter, JP
    Waisfisz, Q
    Rooimans, MA
    van Berkel, CGM
    Bosnoyan-Collins, L
    Alon, N
    Carreau, M
    Bender, O
    Demuth, I
    Schindler, D
    Pronk, JC
    Arwert, F
    Hoehn, H
    Digweed, M
    Buchwald, M
    Joenje, H
    [J]. NATURE GENETICS, 1998, 20 (03) : 281 - 283
  • [12] Isolation of a cDNA representing the Fanconi anemia complementation group E gene
    de Winter, JP
    Léveillé, F
    van Berkel, CGM
    Rooimans, MA
    van der Weel, L
    Steltenpool, J
    Demuth, I
    Morgan, NV
    Alon, N
    Bosnoyan-Collins, L
    Lightfoot, J
    Leegwater, PA
    Waisfisz, Q
    Komatsu, K
    Arwert, F
    Pronk, JC
    Mathew, CG
    Digweed, M
    Buchwald, M
    Joenje, H
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 67 (05) : 1306 - 1308
  • [13] The Fanconi anemia protein FANCF forms a nuclear complex with FANCA, FANCC and FANCG
    de Winter, JP
    van der Weel, L
    de Groot, J
    Stone, S
    Waisfisz, Q
    Arwert, F
    Scheper, RJ
    Kruyt, FAE
    Hoatlin, ME
    Joenje, H
    [J]. HUMAN MOLECULAR GENETICS, 2000, 9 (18) : 2665 - 2674
  • [14] Interaction of the fanconi anemia proteins and BRCA1 in a common pathway
    Garcia-Higuera, I
    Taniguchi, T
    Ganesan, S
    Meyn, MS
    Timmers, C
    Hejna, J
    Grompe, M
    D'Andrea, AD
    [J]. MOLECULAR CELL, 2001, 7 (02) : 249 - 262
  • [15] Phenotypic correction of primary Fanconi anemia T cells with retroviral vectors as a diagnostic tool
    Hanenberg, H
    Batish, SD
    Pollok, KE
    Vieten, L
    Verlander, PC
    Leurs, C
    Cooper, RJ
    Göttsche, K
    Haneline, L
    Clapp, DW
    Lobitz, S
    Williams, DA
    Auerbachc, AD
    [J]. EXPERIMENTAL HEMATOLOGY, 2002, 30 (05) : 410 - 420
  • [16] Biallelic inactivation of BRCA2 in Fanconi anemia
    Howlett, NG
    Taniguchi, T
    Olson, S
    Cox, B
    Waisfisz, Q
    de Die-Smulders, C
    Persky, N
    Grompe, M
    Joenje, H
    Pals, G
    Ikeda, H
    Fox, EA
    D'Andrea, AD
    [J]. SCIENCE, 2002, 297 (5581) : 606 - 609
  • [17] The genomic organization of the Fanconi anemia group A (FAA) gene
    Ianzano, L
    DApolito, M
    Centra, M
    Savino, M
    Levran, O
    Auerbach, AD
    CletonJansen, AM
    Doggett, NA
    Pronk, JC
    Tipping, AJ
    Gibson, RA
    Mathew, CG
    Whitmore, SA
    Apostolou, S
    Callen, DF
    Zelante, L
    Savoia, A
    [J]. GENOMICS, 1997, 41 (03) : 309 - 314
  • [18] CLASSIFICATION OF FANCONI-ANEMIA PATIENTS BY COMPLEMENTATION ANALYSIS - EVIDENCE FOR A 5TH GENETIC SUBTYPE
    JOENJE, H
    LO TEN FOE, JR
    OOSTRA, AB
    VANBERKEL, CGN
    ROOIMANS, MA
    SCHROEDERKURTH, T
    WEGNER, RD
    GILLE, JJP
    BUCHWALD, M
    ARWERT, F
    [J]. BLOOD, 1995, 86 (06) : 2156 - 2160
  • [19] A 20-year perspective on the International Fanconi Anemia Registry (IFAR)
    Kutler, DI
    Singh, B
    Satagopan, J
    Batish, SD
    Berwick, M
    Giampietro, PF
    Hanenberg, H
    Auerbach, AD
    [J]. BLOOD, 2003, 101 (04) : 1249 - 1256
  • [20] Sequence variation in the Fanconi anemia gene FAA
    Levran, O
    Erlich, T
    Magdalena, N
    Gregory, JJ
    Batish, SD
    Verlander, PC
    Auerbach, AD
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (24) : 13051 - 13056